Synerheal Pharmaceuticals Private Limited, a active private limited company, was established on 06 April 2015 in Chennai City Corporation, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24297TN2015PTC099937. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Naveed Ahmed (Director), Perumal Sathiamurthi (Director), Amala Parachuru (Director). Past directors included Subramaniam Sridhar, Tanya Mani, Perumal Sathiamurthi. It holds ₹4.42 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.20, 1St Avenue Road, Second Floor, Shastri Nagar, Chennai City Corporation, Tamil Nadu, 600020.
U24297TN2015PTC099937
099937
06 April 2015
₹0.50 M
₹0.50 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Synerheal Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naveed Ahmed | Director | 06 Apr 2015 | Current |
| Perumal Sathiamurthi | Director | 26 Apr 2024 | Current |
| Amala Parachuru | Director | 26 Apr 2024 | Current |
| Selvaraj Deepa | Director | 26 Jul 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jun 2015 | Past |
| Pramod Abcsdd | Director | 23 Oct 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 21 May 2024 | Past |
| Pramod Abcsdd | Director | 23 Oct 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Synerheal Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 75.8% increase in profit. The company's net worth dipped by a decrease of 0.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Synerheal Pharmaceuticals had a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹44,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2025 | Idbi Bank Limited | ₹4.42 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Synerheal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Synerheal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synerheal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Idbi Bank Limited amounted to Rs. 44.20 M with Charge ID 101126323 was registered on 26 Jun 2025. was recorded as a recent event.
Progress on Synerheal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Selvaraj Deepa was appointed as a Director was appointed as a Director on 26 Jul 2024 & has been associated with this company since 1 year 4 months . was documented.
Progress on Perumal Sathiamurthi was appointed as a Director was appointed as a Director on 26 Apr 2024 & has been associated with this company since 1 year 7 months . was documented.
Progress on Amala Parachuru was appointed as a Director was appointed as a Director on 26 Apr 2024 & has been associated with this company since 1 year 7 months . was documented.
Synerheal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
The CIN of Synerheal Pharmaceuticals Private Limited is U24297TN2015PTC099937.
Synerheal Pharmaceuticals Private Limited is headquartered at No.20, 1St Avenue Road, Second Floor, Shastri Nagar, Chennai City Corporation, Tamil Nadu, 600020.
Synerheal Pharmaceuticals Private Limited was incorporated on 06 April 2015.
The current directors of Synerheal Pharmaceuticals Private Limited are
The primary industry of Synerheal Pharmaceuticals Private Limited is Manufacturing.
Synerheal Pharmaceuticals Private Limited is unlisted.
The authorized capital of Synerheal Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Synerheal Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX